Rob C. M. de Jong

Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia

Dyantha I. van der Lee, Rogier M. Reijmers, Maria W. Honders et al. · Journal of Clinical Investigation · 2019 · 230 citations · Full text

Life Sciences, Immunology, Oncology +17

Inhibition of 14q32 MicroRNAs miR-329, miR-487b, miR-494, and miR-495 Increases Neovascularization and Blood Flow Recovery After Ischemia

S. Welten, A.J.N.M. Bastiaansen, Rob C. M. de Jong et al. · Circulation Research · 2014 · 142 citations

Medicine, Biomedical Sciences, Molecular Medicine +16

T-cell co-stimulation by CD28–CD80/86 and its negative regulator CTLA-4 strongly influence accelerated atherosclerosis development

M.M. Ewing, Jacco C. Karper, S. Abdul et al. · International Journal of Cardiology · 2013 · 128 citations

Life Sciences, Cell Biology, Immunology +17

Annexin A5 reduces infarct size and improves cardiac function after myocardial ischemia-reperfusion injury by suppression of the cardiac inflammatory response

Rob C. M. de Jong, Niek J. Pluijmert, Margreet R. de Vries et al. · Scientific Reports · 2018 · 50 citations · Full text

Medicine, Cardiology, Cell Biology +14

The epigenetic factor PCAF regulates vascular inflammation and is essential for intimal hyperplasia development

Rob C. M. de Jong, M.M. Ewing, Margreet R. de Vries et al. · PLoS ONE · 2017 · 45 citations · Full text

Veterinary Medicine, Cardiology, Immunology +17